Preeclampsia and the anti-angiogenic state

Pregnancy Hypertension

Volumn 1, Issue 1, 2011, Pages 17-21

  Agarwal, Isha ^a   Karumanchi, S Ananth ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Angiogenesis; Endoglin; Glomerular endotheliosis; Hypertension; VEGF

Indexed keywords

ENDOGLIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN RECEPTOR 1;

ENDOTHELIAL DYSFUNCTION; FETUS MORTALITY; GENOTYPE ENVIRONMENT INTERACTION; GLOMERULUS FILTRATION RATE; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PREDICTION; PREECLAMPSIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 78751519412     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2010.10.007     Document Type: Review

References (58)

1. J. Villar, E. Abalos, J.M. Nardin, M. Merialdi, and G. Carroli Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials Semin Nephrol 24 6 2004 607 615
2. A. Wang, S. Rana, and S.A. Karumanchi Preeclampsia: the role of angiogenic factors in its pathogenesis Physiology (Bethesda) 24 2009 147 158
3. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 649 658
4. Y. Bdolah, V.P. Sukhatme, and S.A. Karumanchi Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights Semin Nephrol 24 6 2004 548 556
5. M. Zygmunt, F. Herr, K. Munstedt, U. Lang, and O.D. Liang Angiogenesis and vasculogenesis in pregnancy Eur J Obstet Gynecol Reprod Biol 110 Suppl. 1 2003 S10 S18
6. N. Ferrara, and H.P. Gerber The role of vascular endothelial growth factor in angiogenesis Acta Haematol 106 4 2001 148 156
7. V. Tsatsaris, F. Goffin, C. Munaut, J.F. Brichant, M.R. Pignon, and A. Noel Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 11 2003 5555 5563
8. M. Shibuya Structure and function of VEGF/VEGF-receptor system involved in angiogenesis Cell Struct Funct 26 1 2001 25 35
9. A.S. Maharaj, T.E. Walshe, M. Saint-Geniez, S. Venkatesha, A.E. Maldonado, and N.C. Himes VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma J Exp Med 205 2 2008 491 501
10. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1 1997 4 25
11. D.S. Torry, D. Mukherjea, J. Arroyo, and R.J. Torry Expression and function of placenta growth factor: implications for abnormal placentation J Soc Gynecol Invest 10 4 2003 178 188
12. M. Kuroda, T. Oka, Y. Oka, T. Yamochi, K. Ohtsubo, and S. Mori Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells J Clin Endocrinol Metab 80 11 1995 3196 3200
13. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, and M. De Mol Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat Med 7 5 2001 575 583
14. G. Steinberg, E.V. Khankin, and S.A. Karumanchi Angiogenic factors and preeclampsia Thromb Res 123 Suppl. 2 2009 S93 S99
15. Y. Zhou, S.J. Fisher, M. Janatpour, O. Genbacev, E. Dejana, and M. Wheelock Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99 9 1997 2139 2151
16. Y. Zhou, C.H. Damsky, and S.J. Fisher Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99 9 1997 2152 2164
17. S. Maynard, F.H. Epstein, and S.A. Karumanchi Preeclampsia and angiogenic imbalance Annu Rev Med 59 2008 61 78
18. R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, and B.P. Sachs Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 10 2006 992 1005
19. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672 683
20. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, and Y.M. Kim Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649
21. A. Hertig, N. Berkane, G. Lefevre, K. Toumi, H.P. Marti, and J. Capeau Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia Clin Chem 50 9 2004 1702 1703
22. T. Chaiworapongsa, R. Romero, Y.M. Kim, G.J. Kim, M.R. Kim, and J. Espinoza Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 1 2005 3 18
23. R.L. Kendall, and K.A. Thomas Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor Proc Natl Acad Sci USA 90 22 1993 10705 10709
24. S. Ahmad, and A. Ahmed Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia Circ Res 95 9 2004 884 891
25. H. Sugimoto, Y. Hamano, D. Charytan, D. Cosgrove, M. Kieran, and A. Sudhakar Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria J Biol Chem 278 15 2003 12605 12608
26. D. Kanter, M.D. Lindheimer, E. Wang, R.G. Borromeo, E. Bousfield, and S.A. Karumanchi Angiogenic dysfunction in molar pregnancy Am J Obstet Gynecol 202 2 2010 184.e1 184.e5
27. K. Koga, Y. Osuga, T. Tajima, Y. Hirota, T. Igarashi, and T. Fujii Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole Fertil Steril 2009
28. Y. Bdolah, C. Lam, A. Rajakumar, V. Shivalingappa, W. Mutter, and B.P. Sachs Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 198 4 2008 428.e1 428.e6
29. V. Eremina, J.A. Jefferson, J. Kowalewska, H. Hochster, M. Haas, and J. Weisstuch VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 11 2008 1129 1136
30. T.V. Patel, J.A. Morgan, G.D. Demetri, S. George, R.G. Maki, and M. Quigley A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib J Natl Cancer Inst 100 4 2008 282 284
31. T. Kamba, and D.M. McDonald Mechanisms of adverse effects of anti-VEGF therapy for cancer Br J Cancer 96 12 2007 1788 1795
32. S. Sela, A. Itin, S. Natanson-Yaron, C. Greenfield, D. Goldman-Wohl, and S. Yagel A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia Circ Res 102 12 2008 1566 1574
33. C.P. Thomas, J.I. Andrews, N.S. Raikwar, E.A. Kelley, F. Herse, and R. Dechend A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia J Clin Endocrinol Metab 94 7 2009 2524 2530
34. S. Venkatesha, M. Toporsian, C. Lam, J.I. Hanai, T. Mammoto, and Y.M. Kim Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649
35. E. Podjarny, G. Losonczy, and C. Baylis Animal models of preeclampsia Semin Nephrol 24 6 2004 596 606
36. V.C. Sandrim, A.C. Palei, I.F. Metzger, V.A. Gomes, R.C. Cavalli, and J.E. Tanus-Santos Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia Hypertension 52 2 2008 402 407
37. D.B. Carr, M. Epplein, C.O. Johnson, T.R. Easterling, and C.W. Critchlow A sister's risk: family history as a predictor of preeclampsia Am J Obstet Gynecol 193 3 Pt. 2 2005 965 972
38. D.B. Carr, K.M. Newton, K.M. Utzschneider, J. Tong, F. Gerchman, and S.E. Kahn Preeclampsia and risk of developing subsequent diabetes Hypertens Pregnancy 28 4 2009 435 447
39. S.K. Srinivas, A.C. Morrison, C.M. Andrela, and M.A. Elovitz Allelic variations in angiogenic pathway genes are associated with preeclampsia Am J Obstet Gynecol 2010
40. D. Papazoglou, G. Galazios, M.I. Koukourakis, I. Panagopoulos, E.N. Kontomanolis, and K. Papatheodorou Vascular endothelial growth factor gene polymorphisms and pre-eclampsia Mol Hum Reprod 10 5 2004 321 324
41. T. Ranheim, A.C. Staff, and T. Henriksen VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery Acta Obstet Gynecol Scand 80 2 2001 93 98
42. I. Banyasz, S. Szabo, G. Bokodi, A. Vannay, B. Vasarhelyi, and A. Szabo Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia Mol Hum Reprod 12 4 2006 233 236
43. M. Widmer, J. Villar, A. Benigni, A. Conde-Agudelo, S.A. Karumanchi, and M. Lindheimer Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review Obstet Gynecol 109 1 2007 168 180
44. S. Mutze, S. Rudnik-Schoneborn, K. Zerres, and W. Rath Genes and the preeclampsia syndrome J Perinat Med 36 1 2008 38 58
45. J.F. Tuohy, and D.K. James Pre-eclampsia and trisomy 13 Br J Obstet Gynaecol 99 11 1992 891 894
46. R.T. Lie, S. Rasmussen, H. Brunborg, H.K. Gjessing, E. Lie-Nielsen, and L.M. Irgens Fetal and maternal contributions to risk of pre-eclampsia: population based study BMJ 316 7141 1998 1343 1347
47. M.S. Esplin, M.B. Fausett, A. Fraser, R. Kerber, G. Mineau, and J. Carrillo Paternal and maternal components of the predisposition to preeclampsia N Engl J Med 344 12 2001 867 872
48. D. Haig Genetic conflicts of pregnancy and childhood S.C. Stearns, Evolution in health and in disease 1999 Oxford University Press Oxford 77 90
49. J.M. Roberts, and H.S. Gammill Preeclampsia: recent insights Hypertension 46 6 2005 1243 1249
50. S.E. Hiby, J.J. Walker, K.M. O'Shaughnessy, C.W. Redman, M. Carrington, and J. Trowsdale Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success J Exp Med 200 8 2004 957 965
51. M. van Dijk, J. Mulders, A. Poutsma, A.A. Konst, A.M. Lachmeijer, and G.A. Dekker Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family Nat Genet 37 5 2005 514 519
52. A. Ohkuchi, C. Hirashima, H. Suzuki, K. Takahashi, M. Yoshida, and S. Matsubara Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia Hypertens Res 2010
53. S. Sunderji, E. Gaziano, D. Wothe, L.C. Rogers, B. Sibai, and S.A. Karumanchi Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 1 2010 40.e1 40.e7
54. J.P. Kusanovic, R. Romero, T. Chaiworapongsa, O. Erez, P. Mittal, and E. Vaisbuch A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 11 2009 1021 1038
55. R. Romero, J.K. Nien, J. Espinoza, D. Todem, W. Fu, and H. Chung A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 1 2008 9 23
56. J.S. Gilbert, J. Verzwyvelt, D. Colson, M. Arany, S.A. Karumanchi, and J.P. Granger Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia- induced hypertension Hypertension 55 2 2010 380 385
57. Z. Li, Y. Zhang, J. Ying Ma, A.M. Kapoun, Q. Shao, and I. Kerr Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia Hypertension 50 4 2007 686 692
58. S.A. Karumanchi, and F.H. Epstein Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia? Kidney Int 71 10 2007 959 961